A randomized, double-blind, placebo-controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer's disease: A pilot study

INTRODUCTION: Human studies on low-dose resveratrol are scarce. This study aims to evaluate the safety, tolerability, and efficacy of an oral preparation of resveratrol, glucose, and malate (RGM) in slowing the progression of Alzheimer's disease (AD). METHODS: Thirty-nine subjects with mild to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Carolyn W., Grossman, Hillel, Neugroschl, Judith, Parker, Susan, Burden, Amanda, Luo, Xiaodong, Sano, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Featured Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240843/
https://www.ncbi.nlm.nih.gov/pubmed/30480082
http://dx.doi.org/10.1016/j.trci.2018.09.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240843/
https://www.ncbi.nlm.nih.gov/pubmed/30480082
http://dx.doi.org/10.1016/j.trci.2018.09.009

Ejemplares similares